Thema
Antibodies, Monoclonal, Humanized
315
Angiogenesis Inhibitors
253
Journal Article
246
Vascular Endothelial Growth Factor A
183
Ranibizumab
171
ZL1R02VT79
171
Research Support, Non-U.S. Gov't
160
2S9ZZM9Q9V
133
Bevacizumab
133
VEGFA protein, human
131
Randomized Controlled Trial
128
Antibodies, Monoclonal
124
Multicenter Study
117
Comparative Study
71
Letter
64
Clinical Trial, Phase III
55
Comment
45
Research Support, N.I.H., Extramural
40
Angiogenesis Inhibitors - therapeutic use
34
Antibodies, Monoclonal, Humanized - therapeutic use
34
Vascular Endothelial Growth Factor A - antagonists & inhibitors
26
EC 2.7.10.1
22
Case Reports
21
Visual Acuity - physiology
20
Wet Macular Degeneration - drug therapy
19
Receptors, Vascular Endothelial Growth Factor
18
Clinical Trial, Phase II
17
F446C597KA
17
Photosensitizing Agents
17
Porphyrins
17
Recombinant Fusion Proteins
17
Triamcinolone Acetonide
17
Glucocorticoids
16
0X9PA28K43
15
15C2VL427D
15
Verteporfin
15
aflibercept
15
Klinische Studie
13
Angiogenesis Inhibitors - adverse effects
10
Antibodies, Monoclonal, Humanized - adverse effects
10
Diabetic Retinopathy - drug therapy
10
Macular Edema - drug therapy
10
Tumor Necrosis Factor-alpha
10
XSZ53G39H5
10
brolucizumab
10
Wet Macular Degeneration - diagnosis
9
Wet Macular Degeneration - physiopathology
9
2H1PA8H1EN
8
Anti-Inflammatory Agents
8
Aptamers, Nucleotide
8
mehr ...